Navigation Links
Cardium Reports on Second Quarter 2009 Financial Results and Recent Developments
Date:8/11/2009

SAN DIEGO, Aug. 11 /PRNewswire-FirstCall/ -- Cardium Therapeutics (NYSE Amex: CXM) today reported its financial results for its second quarter ended June 30, 2009, and on recent developments and future outlook.

(Logo: http://www.newscom.com/cgi-bin/prnh/20051018/CARDIUMLOGO)

Cardium made significant progress since first quarter 2009 financial report and highlights included (1) the sale of its InnerCool Therapies business to Royal Philips Electronics; (2) the completion of enrollment of the MATRIX 2b clinical trial of Excellarate for the potential treatment of diabetic ulcers with full data to be announced in late September 2009; and (3) the announcement of the Company's new orthobiologics initiative which is designed to build on and extend the underlying technology that has been developed by the Tissue Repair Company for soft tissue injuries such as diabetic ulcers to hard tissue applications such as bone. The Company's new orthobiologics initiative combines (i) proprietary Gene Activated Matrix(TM) or GAM(TM) delivery and ligand targeting; (ii) use of GAM to locally produce proteins capable of stimulating bone and other tissue growth; and (iii) a substantial body of pre-clinical research and development supporting the use of GAM to deliver bone growth factors. It was also reported that the Company regained its listing compliance with the NYSE Amex.

In addition, as initially reported in November 2008, Cardium instituted several important strategic actions intended to focus its overall operating structure and generate cost efficiencies. Based on these actions, cost savings have begun to be reflected in the Company's operating results. In particular, for the first six months of 2009, Cardium's loss f
'/>"/>

SOURCE Cardium Therapeutics
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13

Related medicine news :

1. Cardium Completes Sale of InnerCool Therapies Business to Royal Philips Electronics
2. Cardium Receives Preliminary Notification of Inclusion in the Russell 3000(R) Index and Russell Global(R) Index
3. Cardium Presents Gene Activated Matrix Technology and Update on Excellarate Clinical Development Program at ASGT Annual Meeting
4. Cardium Reports on First Quarter 2009 Financial Results and Recent Developments
5. Cardium Reports on New Excellarate(TM) Product Formulations to Expand Commercialization Potential Into Multiple Wound Healing Applications
6. Cardium Provides Update Regarding Exchange Listing Compliance Plan Accepted by NYSE Amex
7. Cardiums InnerCool Announces Journal of Neurotrauma Highlights Hypothermia Therapys Role in Post Cardiac Arrest, and Traumatic Brain and Spinal Cord Injury Patients
8. Cardium Reports on Recent Highlights, Financial Results and 2009 Outlook
9. Cardiums Exchange Listing Compliance Plan Accepted by NYSE Alternext US
10. Cardiums InnerCool Reports on Expanding Use of Therapeutic Hypothermia
11. Cardiums InnerCool Announces Launch of New Enhanced Website
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/26/2014)... “Many people become overwhelmed by the ... issues and phone calls with insurance companies,” The Jones ... their free eBook on pedestrian and bicycle accidents ... and bicycle auto accident claims assures the injured individual ... professionally handling their case while they focus on recovering. ...
(Date:12/26/2014)... PA (PRWEB) December 26, 2014 Pentec ... Work in the state of Pennsylvania for 2014. The ... first statewide programs of its kind in the country. ... Foundation, the Pennsylvania Department of Community and Economic Development, ... Resource Management and the Central Penn Business Journal. ...
(Date:12/26/2014)... (PRWEB) December 26, 2014 Parker ... for the best in heating, cooling and plumbing ... 24 hour emergency services in 2014 with regard ... know that Arizona is known for its incredibly ... that understands the intricacies and details of a ...
(Date:12/25/2014)... (PRWEB) December 26, 2014 This is ... of the global Sterilizers industry with a focus on ... the market status of the Sterilizers manufacturers and is ... and individuals interested in the industry. This report provides ... applications and manufacturing technology. In this part, the report ...
(Date:12/25/2014)... December 26, 2014 The report ... to 2023” focuses on the current treatment landscape, ... the colorectal cancer market. Stivarga is a drug ... or rectal cancer. Boehringer Ingelheim is developing nintedanib ... treatment of refractory CRC in the US, Europe, ...
Breaking Medicine News(10 mins):Health News:Guide to Handling Pedestrian and Bicycle Accidents Released By The Jones Firm, Featured in Recent Article 2Health News:Pentec Health Ranks Fourteenth on The Best Places to Work in PA for 2014 2Health News:Pentec Health Ranks Fourteenth on The Best Places to Work in PA for 2014 3Health News:Parker & Sons Announces Record Demand For 24 Hour Emergency Services In 2014 With Regard To Air-Conditioning Systems 2Health News:Parker & Sons Announces Record Demand For 24 Hour Emergency Services In 2014 With Regard To Air-Conditioning Systems 3Health News:Sterilizers Industry Global and Chinese Analysis for 2009-2019 Now Available at ReportsnReports.com 2Health News:Sterilizers Industry Global and Chinese Analysis for 2009-2019 Now Available at ReportsnReports.com 3Health News:Nintedanib Colorectal Cancer Market Analysis and Forecast to 2023 Report at RnRMarketReserach.com 2Health News:Nintedanib Colorectal Cancer Market Analysis and Forecast to 2023 Report at RnRMarketReserach.com 3Health News:Nintedanib Colorectal Cancer Market Analysis and Forecast to 2023 Report at RnRMarketReserach.com 4
... -- New research suggests that depression and other factors ... cancer from getting screenings that could pick up signs ... make people more inattentive to potential risks to their ... their risk," said study researcher Amelie G. Ramirez, professor ...
... Dotinga HealthDay Reporter , THURSDAY, Sept. 22 ... and Hispanic women with breast cancer suffer more stress ... stress to more aggressive tumors. But, the study ... provide insight into whether the women,s stress levels already ...
... FL (Sept. 23, 2011) -- The University of South ... received a $1.59-million U.S. Department of Defense award for ... and veterans and improve military preparedness. The award ... a specific exercise training regimen may protect against low ...
... Amanda Gardner HealthDay Reporter , THURSDAY, Sept. ... through the credibility of claims that a virus likely ... from nine different labs around the United States failed ... on the basis of whether they tested positive for ...
... CITY)University of Utah biochemist Brenda L. Bass, Ph.D., has ... That bent hasn,t come without risks ... of biochemistry who researches double-stranded RNA (dsRNA), an elusive ... But Bass has made substantial discoveries involving dsRNA in ...
... -- Among U.S. patients aged 40 and older with chronic ... hospital readmission, a new report reveals. COPD, a common ... worse over time, includes two main conditions: emphysema and chronic ... days were 30 percent higher among blacks than Hispanics or ...
Cached Medicine News:Health News:Depression After Cancer Keeps Some From Follow-Up Care 2Health News:Study Suggests Link Between Stress and Aggressive Breast Cancer 2Health News:Study Suggests Link Between Stress and Aggressive Breast Cancer 3Health News:US Department of Defense awards University of South Florida $1.59 million for musculoskeletal research 2Health News:US Department of Defense awards University of South Florida $1.59 million for musculoskeletal research 3Health News:US Department of Defense awards University of South Florida $1.59 million for musculoskeletal research 4Health News:US Department of Defense awards University of South Florida $1.59 million for musculoskeletal research 5Health News:New Report Casts More Doubt on Virus' Link to Chronic Fatigue Syndrome 2Health News:New Report Casts More Doubt on Virus' Link to Chronic Fatigue Syndrome 3Health News:Utah biochemist Brenda L. Bass wins NIH Pioneer Award 2Health News:Utah biochemist Brenda L. Bass wins NIH Pioneer Award 3Health News:Utah biochemist Brenda L. Bass wins NIH Pioneer Award 4Health News:Lung Disease Puts Many Black Patients Back in Hospital: Report 2
(Date:12/22/2014)... N.J. , Dec. 22, 2014  CytoSorbents ... marketing its CytoSorb® blood purification technology to help ... patients in 28 countries worldwide, today announced the ... , MD, FACS, as its Senior Vice President ... Dr. Di Russo is ...
(Date:12/22/2014)... , Dec. 22, 2014   TRU-D SmartUVC ... no-touch UV disinfection robot, announced today that the General ... contract through November 2019.   This newly ... engage all levels of government purchasers, including Department of ... well as Homeland Security contacts purchasing solutions for the ...
(Date:12/22/2014)... and STOCKHOLM , Dec. 22, ... and partner Auxilium Pharmaceuticals, Inc. today announced that the ... the European Medicines Agency (EMA) has adopted a positive ... for the treatment of adult men with Peyronie,s disease ... least 30 degrees at the start of therapy. ...
Breaking Medicine Technology:CytoSorbents Appoints Dr. Gregory B. Di Russo as Senior Vice President of Clinical Development 2CytoSorbents Appoints Dr. Gregory B. Di Russo as Senior Vice President of Clinical Development 3CytoSorbents Appoints Dr. Gregory B. Di Russo as Senior Vice President of Clinical Development 4CytoSorbents Appoints Dr. Gregory B. Di Russo as Senior Vice President of Clinical Development 5TRU-D SmartUVC LLC Awarded General Services Administration Contract to Expand Government Customer Base 2Sobi's Xiapex receives positive opinion by CHMP for the treatment of Peyronie's disease 2Sobi's Xiapex receives positive opinion by CHMP for the treatment of Peyronie's disease 3Sobi's Xiapex receives positive opinion by CHMP for the treatment of Peyronie's disease 4Sobi's Xiapex receives positive opinion by CHMP for the treatment of Peyronie's disease 5Sobi's Xiapex receives positive opinion by CHMP for the treatment of Peyronie's disease 6
... Netherlands , February 9 Hoya,announces the appointment of Mr. ... the 1st of April 2010 . He will report to Mr. ... the past 5 years. Mr.,Bottero will remain CEO of Hoya Vision Care ... in the optical industry and is,currently President of Hoya Lens Belgium and ...
... PORTLAND, Ore. , Feb. 8 Rapid ... increase in the use and cost of "specialty" medications to ... led to some inappropriate selection of these medications, higher overall ... and medical benefits.  Regence has introduced a new solution with ...
Cached Medicine Technology:New CEO for Hoya Vision Care Europe 2RegenceRx Leads the Industry With Introduction of Medication Cost Integration 2RegenceRx Leads the Industry With Introduction of Medication Cost Integration 3
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
Medicine Products: